Testing Laboratories - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Testing industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Testing Laboratories - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Testing Laboratories
Corporate Insider Buy Sell Ratio (Insider Count) - Testing Laboratories
Testing Laboratories - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2019-02-28 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D 8.03 10,000
2019-02-28 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER M - Exercise D -20,000
2019-02-28 NEO / NeoGenomics, Inc. 4 BALLIET JENNIFER S - Sale D 19.57 -30,000
2019-02-27 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D 3.45 -30,000
2019-02-27 NEO / NeoGenomics, Inc. 4 CARDOZA GEORGE M - Exercise D 3.45 30,000
2019-02-27 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 18.90 -252,881
2019-02-27 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By self as Trustee for Steven and Carisa Jones 401k and Trust S - Sale I 18.78 -32,371
2019-02-27 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. S - Sale D 19.23 -44,135
2019-02-26 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D -119,348
2019-02-26 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D 7.52 20,037
2019-02-26 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D 8.03 40,166
2019-02-26 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D -40,166
2019-02-26 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D 7.15 119,348
2019-02-26 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D -66,666
2019-02-26 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. M - Exercise D 7.52 66,666
2019-02-26 NEO / NeoGenomics, Inc. 4 Bonello William M - Exercise D -20,037
2019-02-26 NEO / NeoGenomics, Inc. 4 HIPP RAYMOND R M - Exercise D 4.78 10,000
2019-02-26 NEO / NeoGenomics, Inc. 4 HIPP RAYMOND R M - Exercise D -10,000
2019-02-26 NEO / NeoGenomics, Inc. 4 HIPP RAYMOND R M - Exercise D -5,556
2019-02-26 NEO / NeoGenomics, Inc. 4 HIPP RAYMOND R M - Exercise D -3,333
2019-02-26 NEO / NeoGenomics, Inc. 4 HIPP RAYMOND R M - Exercise D 9.11 5,556
2019-02-26 NEO / NeoGenomics, Inc. 4 HIPP RAYMOND R M - Exercise D 7.27 3,333
2019-02-26 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By Aspen Select Opportunity Fund S - Sale I 19.24 -11,721
2019-02-26 NEO / NeoGenomics, Inc. 4 HIPP RAYMOND R S - Sale D 18.90 -18,889
2019-02-26 NEO / NeoGenomics, Inc. 4 JONES STEVEN C By self as Trustee for Steven and Carisa Jones 401k and Trust S - Sale I 19.27 -1,900
2019-02-26 NEO / NeoGenomics, Inc. 4 SHOVLIN ROBERT J. S - Sale D 18.88 -141,879
2019-02-26 NEO / NeoGenomics, Inc. 4 JONES STEVEN C Shares owned in IRA, custodian accounts, and trusts for the family of Steven Jones S - Sale I 19.24 -1,000
2019-02-26 NEO / NeoGenomics, Inc. 4 Bonello William S - Sale D 18.90 -60,203
2019-01-24 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.4749 50,000
2019-01-23 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.4611 90,000
2019-01-22 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.4435 60,000
2019-01-18 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.4448 100,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Peterson Todd A D - Sale to Issuer D -100,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Denkin Todd D - Sale to Issuer D -2,500,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Orser Cindy Sue D - Sale to Issuer D -100,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Denkin Todd D - Sale to Issuer D -500,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Orser Cindy Sue D - Sale to Issuer D -200,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Orser Cindy Sue A - Award D 200,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Denkin Todd A - Award D 2,500,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Denkin Todd A - Award D 500,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Orser Cindy Sue A - Award D 500,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Orser Cindy Sue A - Award D 100,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 Peterson Todd A A - Award D 100,000
2019-01-07 DIGP / Hypha Labs, Inc. 4 RABEN BRUCE I A - Award D 500,000
2019-01-07 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.4657 216,000
2019-01-03 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.4354 154,000
2018-12-31 APDN / Applied DNA Sciences, Inc. 4 Montgomery William W P - Purchase D 0.3713 30,000
2018-12-25 DIGP / Hypha Labs, Inc. 4 Peterson Todd A A - Award D 115,652
2018-12-25 DIGP / Hypha Labs, Inc. 4 Denkin Todd A - Award D 46,261
2018-12-21 NEO / NeoGenomics, Inc. 4 Johnson Kevin C P - Purchase D 11.60 26,000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)